Skip to content

Search

Showing results for "1"

Kids 'rock' out at diabetes camp

Diabetes WA and Perth Children’s Hospital’s recent camp proved to be a “rock-star” hit for kids living with type 1 diabetes.

The diabetes trial changing lives

Seventeen-year-old Andrew says he has a better handle on managing his type 1 diabetes since taking part in an at-home research trial involving a sophisticated new pump system. Watch Andrew, his mum Leeanne and The Kids researcher Professor Tim Jones discuss the trial on Today Tonight.

Better support for students with diabetes

Great news for children living with type 1 diabetes following the recent Federal Government announcement of a new $6m training and education program to make it easier for teachers to support students with diabetes in schools.

Well done Karen

Congratulations to Children's Diabetes Centre exercise researcher Dr Karen Rothacker for receiving the prestigious ADS President’s Clinical Young Investigator Award at the 2018 Australasian Diabetes Congress held in Adelaide recently.

Research buddies needed

Are you aged 18-40 years and living with T1D? If so, researchers planning a trial comparing different ways of providing diabetes education need feedback.

DiAthlete Gavin Griffiths talks with ABC Radio

London Olympics torchbearer Gavin Griffiths is living proof that a Type 1 Diabetes diagnosis is no obstacle to making the most out of life.

Videos

Check out the Centre's video library here

Our track record

A list of the Children's Diabetes Centre's research track record.

TrialR: critical enablers and the need for reusable Rare Disease Clinical Trial infrastructure in Western Australia

Citation: MacDonald B, Burmaz M, Baker S, et al. TrialR: critical enablers and the need for reusable Rare Disease Clinical Trial infrastructure in

Realising the potential impact of artificial intelligence for rare diseases – A framework

Rare diseases (RD) are conditions affecting fewer than 1 in 2000 persons, with over 7000 largely genetic RDs affecting 3.5 %-5.9 % of the global population, or approximately 262.9–446.2 million people. The substantial healthcare burden and costs, such as the $1 trillion annual expense in the USA, highlight the urgent need for improved RD management. The International Rare Diseases Research Consortium (IRDiRC) addresses this need through global collaboration, aiming for timely and accurate diagnosis, development of 1000 new therapies, and methodologies to measure impact by 2027.